During the recent session, Sunshine Biopharma Inc (NASDAQ:SBFM)’s traded shares were 22.48 million, with the beta value of the company hitting -1.02. At the last check today, the stock’s price was $2.50, reflecting an intraday gain of 17.85% or $0.38. The 52-week high for the SBFM share is $637.20, that puts it down -25388.0 from that peak though still a striking 15.6% gain since the share price plummeted to a 52-week low of $2.11. The company’s market capitalization is $5.00M, and the average intraday trading volume over the past 10 days was 99080.0 shares, and the average trade volume was 169.28K shares over the past three months.
Sunshine Biopharma Inc (NASDAQ:SBFM) trade information
Sunshine Biopharma Inc (SBFM) registered a 17.85% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 17.85% in intraday trading to $2.50, hitting a weekly high. The stock’s 5-day price performance is 6.55%, and it has moved by -16.99% in 30 days. Based on these gigs, the overall price performance for the year is -99.50%. The short interest in Sunshine Biopharma Inc (NASDAQ:SBFM) is 0.37 million shares and it means that shorts have 4.13 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sunshine Biopharma Inc (SBFM) estimates and forecasts
In the rating firms’ projections, revenue will increase 83.04% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 15.5M as predicted by 1 analyst(s).
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 73.50%. While earnings are projected to return -260.53% in 2024.
SBFM Dividends
Sunshine Biopharma Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Sunshine Biopharma Inc (NASDAQ:SBFM)’s Major holders
Sunshine Biopharma Inc insiders own 0.23% of total outstanding shares while institutional holders control 1.84%, with the float percentage being 1.85%.
Data provided on Aug 31, 2024 indicates that Fidelity NASDAQ Composite Index Fund owns about 11.0 shares. This amounts to just over 0.00 percent of the company’s overall shares, with a $27.0 market value.
